These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 26341695)
81. A Programmed Nanoparticle with Self-Adapting for Accurate Cancer Cell Eradication and Therapeutic Self-Reporting. Luo Y; Huang L; Yang Y; Zhuang X; Hu S; Ju H; Yu BY; Tian J Theranostics; 2017; 7(5):1245-1256. PubMed ID: 28435462 [TBL] [Abstract][Full Text] [Related]
82. Evolving Important Role of Lutetium-177 for Therapeutic Nuclear Medicine. Pillai AM; Knapp FF Curr Radiopharm; 2015; 8(2):78-85. PubMed ID: 25771380 [TBL] [Abstract][Full Text] [Related]
92. NaCl Nanoparticles as a Cancer Therapeutic. Jiang W; Yin L; Chen H; Paschall AV; Zhang L; Fu W; Zhang W; Todd T; Yu KS; Zhou S; Zhen Z; Butler M; Yao L; Zhang F; Shen Y; Li Z; Yin A; Yin H; Wang X; Avci FY; Yu X; Xie J Adv Mater; 2019 Nov; 31(46):e1904058. PubMed ID: 31553099 [TBL] [Abstract][Full Text] [Related]
93. Modelling of the Bhardwaj R; Wolterbeek HT; Denkova AG; Serra-Crespo P Appl Radiat Isot; 2020 Dec; 166():109261. PubMed ID: 32961525 [TBL] [Abstract][Full Text] [Related]
94. Cancer theranostics with ⁶⁴Cu/¹⁷⁷Lu-loaded liposomes. Ehlerding EB; Goel S; Cai W Eur J Nucl Med Mol Imaging; 2016 May; 43(5):938-940. PubMed ID: 26743898 [No Abstract] [Full Text] [Related]
95. Frontiers in radionuclide imaging and therapy, a chemical journey from naturally radioactive elements to targeted theranostic agents. Casini A; Orvig C; Correia JDG Dalton Trans; 2017 Oct; 46(42):14433-14434. PubMed ID: 29057999 [No Abstract] [Full Text] [Related]
96. Characterization and Efficacy of a Nanomedical Radiopharmaceutical for Cancer Treatment. Yao Mattisson I; Bäckström S; Ekengard E; Lekmeechai S; Liu YC; Paris J; Petoral R; Sydoff M; Hansen M; Axelsson O ACS Omega; 2023 Jan; 8(2):2357-2366. PubMed ID: 36687034 [TBL] [Abstract][Full Text] [Related]
97. Bacteriophage Associated Silicon Particles: Design and Characterization of a Novel Theranostic Vector with Improved Payload Carrying Potential. Srinivasan S; Alexander JF; Driessen WH; Leonard F; Ye H; Liu X; Arap W; Pasqualini R; Ferrari M; Godin B J Mater Chem B; 2013 Oct; 1(39):. PubMed ID: 24409342 [TBL] [Abstract][Full Text] [Related]
98. Fibroblast-Activating Protein: Targeting the Roots of the Tumor Microenvironment. Siveke JT J Nucl Med; 2018 Sep; 59(9):1412-1414. PubMed ID: 30097504 [No Abstract] [Full Text] [Related]